Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma-Reference-Cited by-同舟云学术

Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma

Published:2006-02 Issue:2 Volume:76 Page:134-140
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Iannitto Emilio,Minardi Viviana,Callea Vincenzo,Stelitano Caterina,Calvaruso Giuseppina,Tripodo Claudio,Quintini Gerlando,Cantis Stefano,Ambrosetti Achille,Pizzolo Giovanni,Franco Vito,Florena Ada M.,Abbadessa Vincenzo

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2005.00578.x/fullpdf

Reference36 articles.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study;Haematologica;2024-03-14

2. Concurrent Splenic Marginal Zone B Cell Lymphoma and Metastatic Pancreatic Adenocarcinoma Diagnosed on Splenectomy for Suspected Splenic Abscess;Cureus;2023-02-27

3. Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature;Hematology/Oncology and Stem Cell Therapy;2021-06

4. Splenic Marginal Zone Lymphoma and Other Small B-Cell Lymphomas;Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver;2020

5. Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study;Turkish Journal of Hematology;2019-10-21